Recently added
This page was added on 30 March 2023.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Pfizer Australia
Administration route
Intramuscular injection
Vaccine group
Pneumococcal conjugate vaccines
Description:
Registered for use in people aged ≥6 weeks.
20vPCV - 20-valent pneumococcal conjugate vaccine.
Each 0.5 mL dose of vaccine contains:
- 2.0µg each of pneumococcal purified capsular polysaccharide serotypes 1, 3, 4, 5, 6A, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F
- 4.4µg of pneumococcal purified capsular polysaccharide serotype 6B
- Succinic acid
- Polysorbate 80
Antigens are conjugated to approximately 51 µg of non-toxic diphtheria CRM197 protein, adsorbed on 125 µg of aluminium (as aluminium phosphate adjuvant).
For Product Information and Consumer Medicine Information about Prevenar 20 visit the Therapeutics Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Related diseases
Page history
Last updated
Last reviewed